• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[慢性缺血性心脏病的药物治疗的各个方面]

[Various aspects of drug therapy of chronic forms of ischemic heart disease].

作者信息

Kipshidze N N, Chumburidze V B

出版信息

Kardiologiia. 1985 Sep;25(9):37-40.

PMID:2867241
Abstract

Experience in the treatment of over 500 chronic coronary patients with various anti-anginal drugs or their combinations is summarized. Controlled (double blind) and open studies and acute pharmacologic tests demonstrated comparative efficacy of depot-nitrates, beta-blockers, oxyfedrine, cordaron, lidoflazinum, molsidamine (corvaton). The effects on exercise tolerance (bicycle ergometry) with isolated and combined use of the drugs are described. Indications for surgery are discussed.

摘要

总结了使用各种抗心绞痛药物或其组合治疗500多名慢性冠心病患者的经验。对照(双盲)和开放研究以及急性药理试验证明了长效硝酸盐、β受体阻滞剂、奥昔非君、胺碘酮、利多氟嗪、吗多明(脉导敏)的相对疗效。描述了这些药物单独使用和联合使用对运动耐量(自行车测力计)的影响。讨论了手术适应症。

相似文献

1
[Various aspects of drug therapy of chronic forms of ischemic heart disease].[慢性缺血性心脏病的药物治疗的各个方面]
Kardiologiia. 1985 Sep;25(9):37-40.
2
[Effectiveness of treating stenocardia patients with obzidan, corvaton and corinfar based on the indices of spirometric bicycle ergometry and of central hemodynamics].基于肺活量计自行车测力计指标和中心血流动力学指标,观察奥布西丹、考瓦通和可立弗治疗心绞痛患者的疗效
Vrach Delo. 1985 Aug(8):19-21.
3
[Relation between therapeutic efficacy of antianginal preparations in patients with ischemic heart disease and their effect on the rheologic properties of blood].[抗心绞痛制剂对缺血性心脏病患者的治疗效果与其对血液流变学特性的影响之间的关系]
Kardiologiia. 1985 Sep;25(9):55-9.
4
Molsidomine, an effective long-acting anti-anginal drug.莫西赛利,一种有效的长效抗心绞痛药物。
Eur Heart J. 1983 Sep;4(9):655-61. doi: 10.1093/oxfordjournals.eurheartj.a061538.
5
Double-blind, randomized, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol.在接受阿替洛尔β受体阻滞剂治疗的稳定型劳力性心绞痛患者中进行的莫西多明双盲、随机、安慰剂对照研究。
Am Heart J. 1985 Mar;109(3 Pt 2):678-81. doi: 10.1016/0002-8703(85)90680-5.
6
[Current drug therapy of chronic ischemic heart disease].
Ter Arkh. 1986;58(5):132-8.
7
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.雷诺嗪联合阿替洛尔、氨氯地平或地尔硫䓬对严重慢性心绞痛患者运动耐量和心绞痛发作频率的影响:一项随机对照试验。
JAMA. 2004 Jan 21;291(3):309-16. doi: 10.1001/jama.291.3.309.
8
[Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].[新型血管扩张剂莫西赛利治疗心绞痛的测力计研究:与β受体阻滞剂联合应用的价值]
Arch Mal Coeur Vaiss. 1981 Apr;74(4):463-71.
9
[Treatment with sidnonimine derivatives of chronic ischemic heart disease patients].[慢性缺血性心脏病患者的西多尼明衍生物治疗]
Vrach Delo. 1984 Jul(7):79-81.
10
[Effectiveness of using corvaton on patients with unstable stenocardia].
Vrach Delo. 1984 Nov(11):18-21.